Literature DB >> 12608643

Effect of fangchinoline in murine models of multiple organ dysfunction syndrome and septic shock.

M Hristova1, M Yordanov, N Ivanovska.   

Abstract

OBJECTIVE AND
DESIGN: To study the effect of the alkaloid fangchinoline on zymosan-induced multiple organ dysfunction syndrome (MODS) and Escherichia coli (E. coli)-induced septic shock. MATERIAL: Male ICR mice were used. Macrophages were isolated from peritoneal cavity for in vitro study. TREATMENT: Fangchinoline was administered i.p. at a dose of 1 or 5 mg/kg into the mice.
METHODS: MODS was induced by intraperitoneal (i.p.) injection of zymosan at a dose 1.0 or 0.8/g b.w. E. coli-induced septic shock was provoked by i.p. inoculation of 5 x 10(8) bacterial cells into mice. TNF-alpha in serum and supernatants from peritoneal macrophages was detected by the use of L-929 cell cytotoxic assay. Alternative pathway (AP) complement activity was determined by hemolytic assay.
RESULTS: Fangchinoline increased the survival rate in lethal MODS and septic shock. The alkaloid prevented the loss of body weight and liver enlargement in MODS and suppressed serum tumor necrosis factor-alpha (TNF-alpha) accumulation in MODS and septic shock.
CONCLUSIONS: The result suggest that fangchinoline due mainly to its ability to downregulate TNF-alpha production might have protective effect in murine models of zymosan-induced MODS and E. coli-induced septic shock.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12608643     DOI: 10.1007/s000110300007

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  2 in total

1.  Directed evolution of an LBP/CD14 inhibitory peptide and its anti-endotoxin activity.

Authors:  Li Fang; Zhi Xu; Guan-song Wang; Fu-yun Ji; Chun-xia Mei; Juan Liu; Guo-ming Wu
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

2.  Fangchinoline Has an Anti-Arthritic Effect in Two Animal Models and in IL-1β-Stimulated Human FLS Cells.

Authors:  Thea Villa; Mijin Kim; Seikwan Oh
Journal:  Biomol Ther (Seoul)       Date:  2020-09-01       Impact factor: 4.634

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.